M Roselli

539 total citations
10 papers, 450 citations indexed

About

M Roselli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Endocrine and Autonomic Systems. According to data from OpenAlex, M Roselli has authored 10 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Endocrine and Autonomic Systems. Recurrent topics in M Roselli's work include Radiopharmaceutical Chemistry and Applications (2 papers), Indoor Air Quality and Microbial Exposure (2 papers) and Circadian rhythm and melatonin (2 papers). M Roselli is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (2 papers), Indoor Air Quality and Microbial Exposure (2 papers) and Circadian rhythm and melatonin (2 papers). M Roselli collaborates with scholars based in Italy and United States. M Roselli's co-authors include J Schlom, David Colcher, Raffaella Muraro, Pier Luigi Paggiaro, L Baschieri, Mark Bodmer, Daniel Griffiths-King, Andrew Raubitschek, Diane E. Milenic and John R. Adair and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pineal Research and Clinical & Experimental Allergy.

In The Last Decade

M Roselli

10 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Roselli Italy	7	208	152	115	99	74	10	450
Chumak Aa Ukraine	9	89 0.4×	106 0.7×	34 0.3×	27 0.3×	23 0.3×	66	327
D. Carter United States	10	59 0.3×	95 0.6×	135 1.2×	50 0.5×	41 0.6×	15	503
Toshiyasu Iwasaki Japan	12	351 1.7×	118 0.8×	70 0.6×	7 0.1×	173 2.3×	31	494
Sylwia Kabacik United Kingdom	11	308 1.5×	276 1.8×	62 0.5×	11 0.1×	142 1.9×	16	549
Susan E. Lacy United States	10	46 0.2×	252 1.7×	152 1.3×	10 0.1×	29 0.4×	14	465
Radhia M’kacher France	12	110 0.5×	183 1.2×	88 0.8×	17 0.2×	92 1.2×	28	410
Aurélie Vaurijoux France	15	296 1.4×	223 1.5×	49 0.4×	6 0.1×	226 3.1×	25	559
Feinendegen Le Germany	11	145 0.7×	69 0.5×	40 0.3×	8 0.1×	70 0.9×	50	316
Chung‐Ying Huang Taiwan	12	245 1.2×	231 1.5×	69 0.6×	19 0.2×	186 2.5×	18	591
A. Norgren Sweden	14	20 0.1×	96 0.6×	126 1.1×	58 0.6×	32 0.4×	42	680

Countries citing papers authored by M Roselli

Since Specialization

Citations

This map shows the geographic impact of M Roselli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Roselli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Roselli more than expected).

Fields of papers citing papers by M Roselli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Roselli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Roselli. The network helps show where M Roselli may publish in the future.

Co-authorship network of co-authors of M Roselli

This figure shows the co-authorship network connecting the top 25 collaborators of M Roselli. A scholar is included among the top collaborators of M Roselli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Roselli. M Roselli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Comella, P., Sebastian T. Palmeri, R Cioffi, et al.. (2006). Cisplatin(P)-including triplets versus P-free doublets in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC): SICOG 0101 randomized trial. Journal of Clinical Oncology. 24(18_suppl). 7103–7103. 1 indexed citations

Lissoni, Paolo, R Bucovec, Luisa Giani, et al.. (2001). Thrombopoietic properties of 5‐methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer‐related thrombocytopenia. Journal of Pineal Research. 30(2). 123–126. 20 indexed citations

Guadagni, Fiorella, Patrizia Ferroni, S. Carlini, et al.. (2001). A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.. PubMed. 7(8). 2357–62. 96 indexed citations

Lissoni, Paolo, Sandro Barni, Mario Mandalà, et al.. (1998). Immunobiological effects of interleukin-2, interleukin-12 or interleukin-2 plus interleukin-12 in metastatic cancer patients. 14(1). 41–44. 1 indexed citations

Lissoni, Paolo, et al.. (1996). Modulation of cytokine production from TH2-lymphocytes and monocytes by the pineal neurohormone melatonin. Oncology Reports. 3(3). 541–3. 11 indexed citations

Brivio, F, Paolo Lissoni, Luca Fumagalli, et al.. (1995). PREOPERATIVE NEUROIMMUNOTHERAPY WITH SUBCUTANEONS LOW-DOSE INTERLEUKIN-2 AND MELATONIN IN PATIENTS WITH GASTROINTESTINAL TUMORS - ITS EFFICACY IN PREVENTING SURGERY-INDUCED LYMPHOCYTOPENIA. Oncology Reports. 2(4). 597–9. 3 indexed citations

Colcher, David, Diane E. Milenic, M Roselli, et al.. (1989). Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.. PubMed. 49(7). 1738–45. 95 indexed citations

Colcher, David, et al.. (1988). Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.. PubMed. 48(16). 4597–603. 115 indexed citations

Paggiaro, Pier Luigi, et al.. (1984). Follow‐up study of patients with respiratory disease due to toluene diisocyanate (TDI). Clinical & Experimental Allergy. 14(5). 463–469. 94 indexed citations

10.

Paggiaro, Pier Luigi, et al.. (1983). Absence of IgG antibodies to TDI‐HSA in a radioimmunological study. Clinical & Experimental Allergy. 13(1). 75–79. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact